Local Leaders Visit Peak Enterprises
Release time:
2022-03-11
3# On the afternoon of May 1
, Mo Negative Chun, Deputy Director of the Standing Committee of the Shanghai Municipal People's Congress and Chairman of the Municipal Federation of Trade Unions, Lu Xiaodong, Chairman of the Legislative Affairs Committee of the Municipal People's Congress, and Zhang Dezhi, Member of the Party Group and Vice Chairman of the Municipal Federation of Trade Unions, accompanied by the person in charge of Songjiang Economic and Technological Development Zone, visited Shanghai Beika Pharmaceutical Technology Co., Ltd. After listening to the business situation and development demands of the enterprise, Mo negative spring pointed out that the biomedical industry is one of the three major high-tech industries in Shanghai, and there is still huge room for growth in the future. Enterprises should strengthen their confidence, adhere to their original intention, stick to their original intention, further clarify higher, better and better development goals, and lead the development with brand. Local governments and trade union organizations should take good care of enterprises, actively strive for innovation, dare to make breakthroughs, strive to improve industrial policies, provide good conditions for the development of enterprises, optimize the business environment, and better serve enterprises. (Shanghai North Carolina)3 9
, Wang Gang, deputy secretary and mayor of Pu 'er Municipal Committee, and Li Xudong, member of the Standing Committee of the Municipal Committee and Secretary of Simao District Committee, visited Yunnan Jianfeng Cement Company for investigation.This survey is Mayor Wang Gang's first visit to a cement enterprise after taking office. In Yunnan Jianfeng, Wang Gang and his entourage visited the production base, listened to reports on the production and operation status, market expansion, and industrial chain extension of the enterprise, and fully affirmed the operation and development of Yunnan Jianfeng in recent years. Wang Gang pointed out that the Pu'er Municipal Party Committee and Government has always attached great importance to the development of cement companies, supporting companies to further extend the industrial chain and achieve green, sustainable and stable development. All functional departments should strengthen communication with companies to provide more convenient services for companies;
Yunnan Peak should also continue to base itself on existing advantages, actively play a regional demonstration role, and lead and drive the healthy development of the industry, to make new and greater contributions to local economic and social development. (Photo by Hu Chuanli / Wen
Wang Yingliang /) 3 September , Hao Shengyong, member of the Standing Committee of Huangshi Municipal Committee and Secretary of Daye Municipal Committee, and relevant leaders of relevant municipal departments and Baoan Town went to Daye Peak for investigation. Hao Shengyong and his party visited the production site of Daye Peak. Zhang Fengliang, deputy general manager of the group company and general manager of Daye Peak, reported on the production and operation in
2021, and introduced the technological transformation and projects around dual control of energy consumption and "dual carbon" in 2022 . Hao Shengyong fully affirmed Daye Jianfeng's factory environmental construction, production and operation performance, and hoped that Daye Jianfeng would continue to strengthen technological innovation around policies, continuously improve the comprehensive strength of the enterprise, and make new contributions to promoting regional economic development. (Hu Ning)
3January 7 , Zhu Wenming, deputy secretary of the county party Committee and first secretary of the party Committee of the economic development district in the east, Xu Honghe, secretary of the party Committee and director of the administrative Committee of the economic development district in the east, and Jiang Xiaomeng, chairman of the group, and other group leaders and members of the management team of the north card company held a sincere meeting in Anhui Jianfeng north card pharmaceutical company. The North Carolina Company reported the results of the project construction of the two enterprises in Anhui, and analyzed the difficulties faced by the current enterprise development. The leaders of the park affirmed the work achievements of Anhui North Carolina in recent years, and discussed and reached a consensus with the enterprise on the future development goals. (Gan Jiaren)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31